Author: Mark Newman

Share

Congress Approves Continuing Resolution to Fund NIH Through February 18

With just hours to spare before its December 3 deadline, Congress averted a government shutdown and passed a continuing resolution (CR) that will fund the government at the previous year’s level through February 18, 2022. We appreciate the Endocrine Society members who participated in our online campaign, which helped avoid a destabilizing shutdown and ensured...
Share

Advocacy Victory:  EU Effectively Bans BPA in Food Contact Materials 

The European Food Safety Administration (EFSA) issued a draft opinion in December that lowers the ‘tolerable daily intake of BPA in food contact materials by six orders of magnitude – effectively a ban on BPA and an advocacy victory for the Endocrine Society. We have called for better regulation of endocrine-disrupting chemicals in food contact materials.    The Endocrine Society will provide supporting comments to...
Share

Advocacy Victory: Congress Passes Legislation Averting Medicare Cuts

In December, Congress passed legislation to avert a series of Medicare cuts that would have resulted in an almost 10% reduction in Medicare payments to physicians. The Endocrine Society has been a vocal advocate for Congress to avert these alarming cuts, which were scheduled to occur in 2022, and we were pleased to see action...
Share

High Altitude Exercise Could Increase Hypoglycemia Risk in People with Diabetes

People with diabetes may need to monitor their blood sugar more closely when doing high-altitude activities such as hiking or skiing, according to a small study published in the Society’s Journal of Clinical Endocrinology & Metabolism. Doctors often recommend exercise for people with diabetes as it has many benefits. It can improve heart health, insulin sensitivity, and quality of life. However, exercise can also cause hypoglycemia (dangerously low blood sugar) in people with diabetes during and after a workout. If...
Share

Highlighting the Year in Endocrine Discoveries

Mark Headshot As 2021 comes to a close we wrap up the year with two articles that provide a somewhat comprehensive overview of what took place over the course of the year from an endocrine science and treatment perspective. Despite a year that was still feeling the wrath of the COVID-19 pandemic, there was definitely no lack...
Share

EUREKA! The Top Endocrine Discoveries of 2021

december 2021 cover For the seventh year running, Endocrine News talks to editors from Endocrine Society publications to get the endocrine discoveries of 2021 worth their weight in gold. Research never stops. Despite facing challenges related to social distancing, supply chain disruptions, and other pandemic-related problems this past year, scientists dug deep in the mines of endocrinology and...
Share

Gap in Diabetes Technology Use Among Black and White Medicare Beneficiaries is Worsening

The gap in the use of insulin pumps and continuous glucose monitors (CGMs) among Black and white Medicare beneficiaries widened from 2017 to 2019, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Reducing health disparities is a major public health goal in the U.S., and these disparities include the use of diabetes technology. All Medicare beneficiaries with type 1 diabetes...
Share

Endocrine Society Urges Senate to Address Insulin Affordability

The Endocrine Society urges the Senate to protect the insulin affordability provisions included in the Build Back Better Act and move quickly to pass this crucial legislation. We implore all Senators to ensure these provisions are not scaled back. The Build Back Better Act represents the best opportunity to address the price of insulin. Millions...